https://www.revbiosciences.com/home-1 daily 1.0 2026-06-04 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/1695933530596-HA6SE6W7ZD8IQP4OR252/IMG_0516.jpg Home https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/bba07711-1f3d-4c92-9ffe-afb8578c8dd7/Gemini.png Home https://www.revbiosciences.com/press-releases daily 0.75 2026-07-30 https://www.revbiosciences.com/press-releases/8kebnknnmja9onqu28w9wry0p7wt1d-l33s9 monthly 0.5 2026-08-03 https://www.revbiosciences.com/press-releases/0gytbz4d2nwrwcougf2jzcgm3goi8a-3rAAo monthly 0.5 2026-08-03 https://www.revbiosciences.com/press-releases/8kebnknnmja9onqu28w9wry0p7wt1d monthly 0.5 2026-07-21 https://www.revbiosciences.com/press-releases/8f47ald5wbhkqxzdah212xyd3o5eul monthly 0.5 2026-07-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-expands-acute-kidney-injury-advisory-board monthly 0.5 2026-06-01 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-releases-corporate-update-letter-to-stockholders monthly 0.5 2026-05-11 https://www.revbiosciences.com/press-releases/dd3w8r56vnmdn6ri4itai4k0ron2iv monthly 0.5 2026-05-11 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/8740a5f2-2cae-4455-b2d2-8e1545ca482a/Graph1.png News - Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/41ea8b77-efd7-4d74-a13b-ef7ef697c1dd/Graph2.png News - Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/o0xwbi4506ovvkniggvzx74aba6u50 monthly 0.5 2026-04-06 https://www.revbiosciences.com/press-releases/wpt33c1ikz9xq73ys31etcz7vm6ffa monthly 0.5 2026-03-30 https://www.revbiosciences.com/press-releases/u0umkw892186vh1klkbeyz1lyyui2b monthly 0.5 2026-03-24 https://www.revbiosciences.com/press-releases/6sg7zq3cqwwlv4tiehmxowjwzmt5vg monthly 0.5 2026-03-19 https://www.revbiosciences.com/press-releases/rymvqw581anr099mwn9k712wu2zmwv monthly 0.5 2026-02-26 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/1e3c1aa9-81f7-4567-b351-ca2fefee833e/Graph1.png News - Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/07890999-0651-46b8-9783-3f24893f067e/Graph2.png News - Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-1-for-4-reverse-stock-split-effective-january-28-2026 monthly 0.5 2026-02-17 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-exercise-of-warrants-for-11-million-in-gross-proceeds monthly 0.5 2026-01-23 https://www.revbiosciences.com/press-releases/revelation-biosciences-reaches-agreement-with-fda-on-gemini-approval-pathway-for-aki monthly 0.5 2026-01-21 https://www.revbiosciences.com/press-releases/00u7jaicl3vrbnp2nb185se8t33ruo monthly 0.5 2026-01-14 https://www.revbiosciences.com/press-releases/z9ldbvrsvb53awa1fbh3bk1meq21um monthly 0.5 2026-01-12 https://www.revbiosciences.com/press-releases/revelation-biosciences-announces-initiation-of-gmp-manufacturing-of-gemini-and-placebo-to-support-later-stage-clinical-development monthly 0.5 2026-01-07 https://www.revbiosciences.com/press-releases/782ztb8imke9o67wyqwa2kunt1vauz monthly 0.5 2025-12-01 https://www.revbiosciences.com/press-releases/revelation-biosciences-on-track-for-end-of-phase-1-meeting-with-fda-later-this-year monthly 0.5 2025-11-20 https://www.revbiosciences.com/press-releases/e8lxoblttsgknedb0cthnfua9e3g0d monthly 0.5 2025-11-06 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/ddace30d-df1a-492a-96e6-451bfff09b22/Graph1.png News - Revelation Biosciences, Inc. Announces Financial Results for the three and nine months ended September 30, 2025 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/cc1d58ac-17cb-4b05-9306-337ae70f801f/Graph2.png News - Revelation Biosciences, Inc. Announces Financial Results for the three and nine months ended September 30, 2025 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/g94d023fcb0s7wpqjbdurz4qdtnzil monthly 0.5 2025-10-29 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-adjournment-of-october-15-2025-special-meeting-of-stockholders-to-october-29-2025 monthly 0.5 2025-10-15 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-exercise-of-warrants-for-96-million-in-gross-proceeds monthly 0.5 2025-09-11 https://www.revbiosciences.com/press-releases/9d8vwiijq68fxgtpqqwlbfzf7is7b1 monthly 0.5 2025-09-10 https://www.revbiosciences.com/press-releases/reminder-webcastconference-call-to-discuss-fantastic-prime-phase-1b-top-line-data monthly 0.5 2025-09-09 https://www.revbiosciences.com/press-releases/revelation-biosciences-announces-groundbreaking-top-line-results-from-prime-clinical-study monthly 0.5 2025-09-09 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-financial-results-for-the-three-and-six-months-ended-june-30-2025 monthly 0.5 2025-08-08 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/9091de74-ed09-4b48-a0ac-ba10780aa253/2025-08-08_05-14-14.png News - Revelation Biosciences, Inc. Announces Financial Results for the three and six months ended June 30, 2025 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/7834ddba-14a2-424b-a4bc-04fcd6f4a8c4/2025-08-08_05-14-58.png News - Revelation Biosciences, Inc. Announces Financial Results for the three and six months ended June 30, 2025 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/5x0aq8tu9vz79qforbcpsy94a8oc3h monthly 0.5 2025-07-24 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-completes-dosing-of-patients-in-prime-study monthly 0.5 2025-07-16 https://www.revbiosciences.com/press-releases/jl6klauaj8je23mara2bhcljm4frfa monthly 0.5 2025-07-01 https://www.revbiosciences.com/press-releases/m69pu26r9s3nsjnt3izt0jhe0mlyy2 monthly 0.5 2025-05-29 https://www.revbiosciences.com/press-releases/86w86c0qhq47brt2lodkgqtlch9uma monthly 0.5 2025-05-29 https://www.revbiosciences.com/press-releases/revelation-biosciences-announces-retirement-of-george-tidmarsh-md-phd-from-board-of-directors monthly 0.5 2025-05-27 https://www.revbiosciences.com/press-releases/2kzi2i5b3kfkdron396bck0d9j656k monthly 0.5 2025-05-08 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/7739350c-c1bd-44c6-a554-df694e509bc5/Graph1.png News - Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/0273223a-5fef-4880-9304-0917e5240069/Graph2.png News - Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/i3w4txq4ash20bipyhpxddffbtmgfl monthly 0.5 2025-04-29 https://www.revbiosciences.com/press-releases/ual4f33jdj56gun88i397p6yh9k1gm monthly 0.5 2025-03-17 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/8128e494-3fef-455c-916b-e1288abefc20/Figure+1.png News - Gemini priming attenuates inflammation in human peripheral blood mononuclear cells - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/hl0rdchnvyr63h37ce6ammrdj6y9nl monthly 0.5 2025-03-13 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-financial-results-for-the-three-and-twelve-months-ended-december-31-2024 monthly 0.5 2025-03-06 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/50ef6498-7a30-4824-9a61-404d0bfc0f86/P%26L.png News - Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/b8a76936-d3ba-4be3-9408-2415f8813948/Balance+Sheet.png News - Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/revelation-biosciences-doses-first-patient-in-prime-phase-1b-clinical-study-of-gemini-in-ckd-patients monthly 0.5 2025-02-26 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-receives-continued-nasdaq-listing-approval monthly 0.5 2025-02-26 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-1-for-16-reverse-stock-split-effective-january-28-2025 monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-starts-its-prime-phase-1b-clinical-study-of-gemini-in-ckd-patients monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-reminds-you-to-vote-for-the-special-meeting-on-january-17-2025 monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/nasdaq-grants-revelation-biosciences-inc-continued-listing monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-exercise-of-warrants-for-4-million-in-gross-proceeds monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-fda-acceptance-of-gemini-ind monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-completes-the-gmp-manufacture-of-gemini-clinical-drug-supply monthly 0.5 2024-11-12 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-financial-results-for-the-three-and-nine-months-ended-september-30-2024 monthly 0.5 2025-02-10 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/0b845744-2d8f-4dd7-9084-4a5aef0f6401/2025-02-10_13-28-38.png News - Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/09992205-e464-4551-b09a-5896091fe4bd/2025-02-10_13-28-58.png News - Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/revelation-biosciences-gemini-induces-dose-dependent-significant-increases-in-il-10 monthly 0.5 2025-02-10 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/9fcaf34c-b368-4bc0-8968-f6d65c14e030/2025-02-10_13-34-06.png News - Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-exercise-of-warrants-for-38-million-in-gross-proceeds monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-announces-phase-1-clinical-study-of-gemini-met-the-primary-safety-endpoint-and-showed-statistically-significant-biomarker-activity monthly 0.5 2025-02-10 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/b9baf459-5fc8-41d2-b1dd-633ef89dc02d/2025-02-10_13-38-26.png News - Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met The Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/revelation-biosciences-has-completed-dosing-of-its-first-in-human-phase-1-clinical-study-of-gemini monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/pwwaj364yjwxz0i8x214z692te8pe0 monthly 0.5 2025-02-10 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/9ec459e8-a647-4be8-9f66-ac07bd5c8b08/2025-02-10_13-45-35.png News - Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/045d36c0-c922-4340-a903-6056f427cae3/2025-02-10_13-45-48.png News - Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-gives-oral-presentation-at-advances-in-critical-care-nephrology-aki-amp-crrt-2024 monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-to-participate-in-a-virtual-fireside-chat-at-the-36th-annual-roth-conference monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-commencement-of-first-in-human-phase-1-clinical-study-of-gemini monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-receives-invitation-to-give-an-oral-presentation-at-the-29th-international monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-closing-of-62-million-public-offering monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-pricing-of-62-million-public-offering monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-to-present-at-the-international-conference-on-advances-in-critical-care-nephrology-aki-amp-crrt-2024 monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-1-for-30-reverse-stock-split-effective-january-25-2024 monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-financial-results-for-the-three-and-nine-months-ended-september-30-2023 monthly 0.5 2025-02-10 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/ee09f89d-2500-4041-81aa-85acba98ef8a/2025-02-10_14-17-38.png News - Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/79a6bd47-24db-42f6-b20a-17577458a7df/2025-02-10_14-17-51.png News - Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/gemini-induces-pharmacologic-activity-and-related-physiologic-changes-in-multiple-preclinical-studies monthly 0.5 2025-02-10 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/152777fb-1de6-4d2e-b9d7-7a96f8513d14/2025-02-10_14-23-33.png News - Gemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical Studies - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/1d05b27e-20a9-4c06-b5c7-c04e05fbad44/2025-02-10_14-23-53.png News - Gemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical Studies - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-to-present-at-the-2023-roth-healthcare-opportunities-conference monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-appointment-of-lakhmir-chawla-md-to-board-of-directors monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-financial-results-for-the-three-and-six-months-ended-june-30-2023 monthly 0.5 2025-02-10 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/d54c7a67-b567-4bfd-acde-b35608f969de/2025-02-10_14-28-41.png News - Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/455267fb-d138-4d4f-9849-3aea9d93fc4f/2025-02-10_14-28-54.png News - Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/reminder-revelation-biosciences-inc-urges-all-stockholders-to-vote-at-the-2023-annual-meeting-of-stockholders monthly 0.5 2025-02-10 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/9653ae70-f433-4caf-81b6-954f3db25ec5/2025-02-10_14-32-09.png News - REMINDER: Revelation Biosciences, Inc. Urges All Stockholders to Vote at the 2023 Annual Meeting of Stockholders - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-adjournment-of-2023-annual-meeting-of-stockholders-to-july-7-2023-and-additional-proposal monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-financial-results-for-the-three-months-ended-march-31-2023-and-recent-corporate-progress monthly 0.5 2025-02-10 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/97086268-4c32-427e-a71a-4b89dfd65b9b/2025-02-10_14-38-00.png News - Revelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2023 and Recent Corporate Progress - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/be034233-076a-44f2-9818-41993878ef36/2025-02-10_14-38-05.png News - Revelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2023 and Recent Corporate Progress - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-appoints-dr-julia-bohannon-and-dr-antonio-hernandez-to-scientific-advisory-board monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-closing-of-156-million-public-offering monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-pricing-of-156-million-public-offering monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-preclinical-biomarker-data-supporting-activity-of-revtx-300 monthly 0.5 2025-02-10 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/0aec786d-0373-45c3-b376-e8206220929e/2025-02-10_15-20-13.png News - Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-1-for-35-reverse-stock-split-effective-february-1-2023-and-results-of-special-meeting-of-stockholders monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-mandatory-unit-separation-to-occur-on-january-13-2023 monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-future-clinical-development-plans-based-on-recent-biomarker-analysis-and-significant-reduction-in-new-collagen-deposition-fibrosis-in-preclinical-model monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-positive-results-in-preclinical-model-of-acute-and-chronic-kidney-disease monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-and-vanderbilt-university-enter-exclusive-worldwide-license-agreement monthly 0.5 2025-02-10 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-financial-results-for-the-three-and-six-months-ended-june-30-2022-and-recent-corporate-progress monthly 0.5 2025-02-11 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/2937f7c9-9eca-4fa0-ae4b-d5362a6553cf/2025-02-11_10-15-52.png News - Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2022 and Recent Corporate Progress - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/6c4da123-1487-49ab-a43a-3277397b803d/2025-02-11_10-16-00.png News - Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2022 and Recent Corporate Progress - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-closing-of-5-million-public-offering monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-pricing-of-5-million-public-offering monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-topline-data-for-phase-1b-clear-clinical-study-of-revtx-99b-for-the-treatment-of-allergic-rhinitis monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-completes-database-lock-for-its-phase-1b-clear-clinical-study-of-revtx-99b-for-the-treatment-of-allergic-rhinitis monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-completion-of-dosing-for-a-phase-1b-clear-clinical-study-of-revtx-99b-for-the-treatment-of-allergic-rhinitis monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-safety-monitoring-committee-recommendation-for-continuing-evaluation-of-revtx-99b-for-the-treatment-of-allergic-rhinitis monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-financial-results-for-the-three-months-ended-march-31-2022-and-recent-corporate-progress monthly 0.5 2025-02-11 https://images.squarespace-cdn.com/content/v1/5f536d50b94bfb444769fc95/6a41081e-2c3e-4157-af4d-44f647785514/2025-02-11_12-04-47.png News - Revelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2022 and Recent Corporate Progress - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-conference-call-to-provide-a-corporate-update monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-primary-endpoint-analysis-for-phase-2b-viral-challenge-study-to-assess-efficacy-of-intranasal-revtx-99a-for-the-prevention-of-h3n2-influenza-infection monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-outlines-details-on-the-upcoming-data-analysis-for-phase-2b-viral-challenge-study-to-assess-efficacy-of-intranasal-revtx-99a-for-the-prevention-of-h3n2-influenza-infection monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-to-present-at-the-2022-virtual-growth-conference-presented-by-maxim-group-llc monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/y1wxwdhmh5zpewvnc396par8f3ukcr monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-to-present-at-the-34th-annual-roth-conference monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-to-present-at-2022-bio-ceo-amp-investor-conference monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-raises-776-million-in-equity-financing monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-first-group-of-patients-dosed-in-phase-2b-viral-challenge-study-to-assess-efficacy-of-intranasal-revtx-99-for-the-prevention-of-h3n2-influenza-infection monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/bcn7u5i46bbgiextyey52deaxbcbam monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-data-demonstrating-revtx-99-in-vitro-anti-viral-activity-against-sars-cov-2-commencement-of-trading-as-a-public-company monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/petra-acquisition-inc-announces-share-redemption-backstop-and-forward-purchase-agreements-in-connection-with-revelation-biosciences-inc-business-combination monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/petra-acquisition-inc-announces-special-meeting-of-stockholders-to-approve-business-combination-with-revelation-biosciences-inc monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-initiation-of-a-phase-2b-study-to-assess-efficacy-of-intranasal-revtx-99-for-the-prevention-of-h3n2-influenza monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-creation-and-appointments-to-scientific-advisory-board monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-initiation-of-a-phase-1b-clinical-study-of-revtx-99-for-the-experimental-treatment-of-allergic-rhinitis-and-chronic-nasal-congestion monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-engages-partnering-advisor-medworld-advisors-to-optimize-value-of-the-companys-diagnostic-tool-revid monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-engages-destum-partners-inc-to-identify-a-strategic-partners-for-revtx-99-ex-us-and-revtx-200-worldwide monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-receives-approval-to-begin-a-phase-1b-clinical-study-of-revtx-99-as-an-experimental-treatment-for-allergic-rhinitis-and-chronic-nasal-congestion monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-receives-approval-to-initiate-phase-2b-viral-challenge-study-of-revtx-99-an-experimental-prophylactic-treatment-for-the-prevention-of-respiratory-viral-infections monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-a-life-co-developing-therapeutics-amp-diagnostics-for-respiratory-viral-infections-including-covid-19-to-become-publicly-traded-through-a-merger-with-petra-acquisition-inc monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-to-present-at-2021-bio-digital-conference monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-results-of-phase-1-clinical-study-of-revtx99-an-experimental-therapy-for-the-prevention-of-respiratory-viral-infection monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-to-present-at-bio-ceo-amp-investor-digital-conference monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-completes-dosing-of-five-single-dose-cohorts-and-receives-approval-to-initiate-a-multiple-dose-cohort-to-phase-1-clinical-study-of-revtx99 monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-closing-of-44-million-in-series-a-1-financing monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/curt-labelle-md-appointed-to-revelation-biosciences-inc-board-of-directors monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-91-million-common-stock-and-series-a-financing monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-announces-the-start-of-a-phase-1-clinical-study-for-revtx99-an-experimental-treatment-for-respiratory-viral-infection-including-covid19 monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-appoints-jess-roper-to-board-of-directors monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-receives-tga-acknowledgment-to-start-a-phase-1-clinical-study-of-revtx99-an-experimental-treatment-for-covid19 monthly 0.5 2025-02-11 https://www.revbiosciences.com/press-releases/revelation-biosciences-inc-receives-approval-to-start-a-phase-1-clinical-study-of-revtx99-an-experimental-treatment-for-covid19 monthly 0.5 2025-02-11